1[1]Hankey GJ, Eikeboom JW. Homocysteine and vascular disease Lancet,1999,354: 407-413.
2[3]Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J clin Invest,1993,91:308-313.
3[4]Tsai JC, Parrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine,a link to atherosclerosis. Proc Natl Acad Sci USA,1994,91:6369-6373.
4[5]Harker LA, Slichter SJ, Scott CR, et al. Homocystinemia vascular injury and arterial thrombosis. N Engl J Med, 1974, 291:537-543.
5[6]Rodgers GM, Conn MT. Homocysteine and atherogenic stimulus,reduces protein C activation by arterial and venous endothelial cells. Blood, 1990,75:895-901.
6[7]Blom HJ, Kleinveld HA, Boers GH, et al. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest, 1995,2:149-154.
7[8]Wollesen F, Brattstrom L, Refsum H, et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int,1999,55:1028-1035.
8[9]Mazza A, Giugliano D, Motti C, et al. Glycemia,MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients. Atherosclerosis, 2000,149:223-224.
9[10]Chico A, Pereza A, Cordoba A, et al.Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus:a new link between diabetic nephropathy and cardiovascular disease?Diabetologia,1998,41:684-693.
